| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 52.2698 | 55 |
| GSM780708 | Untreated after 4 days (C2_1) | 55.7357 | 60 |
| GSM780709 | Untreated after 4 days (C3_1) | 58.2907 | 63 |
| GSM780719 | Untreated after 4 days (C1_2) | 53.2647 | 57 |
| GSM780720 | Untreated after 4 days (C2_2) | 52.688 | 55 |
| GSM780721 | Untreated after 4 days (C3_2) | 50.8848 | 51 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.8462 | 58 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 56.2358 | 61 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 54.3506 | 59 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 54.5755 | 59 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.7239 | 35 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 59.8409 | 64 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 55.5568 | 60 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 55.3641 | 60 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 55.032 | 60 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.5569 | 47 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.4346 | 50 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 61.3739 | 65 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 60.1447 | 65 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 52.8716 | 56 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.3517 | 34 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.2062 | 28 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 55.8735 | 61 |